Display Settings:

Format

Send to:

Choose Destination
    Cell Host Microbe. 2009 Oct 22;6(4):292-4.

    Mining the B cell repertoire for broadly neutralizing monoclonal antibodies to HIV-1.

    Source

    Vaccine Research Center, NIAID, National Institutes of Health, Bethesda, MD 20892, USA.

    Abstract

    Monoclonal antibodies that effectively neutralize HIV-1 have been widely sought, yet few have been isolated. Now, technological advances in sera evaluation, B cell stimulation, microneutralization, and antibody cloning have allowed Burton and colleagues to identify two broadly neutralizing monoclonal antibodies, PG9 and PG16, which provide insights for HIV vaccine design.

    PMID:
    19837366
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Icon for Elsevier Science

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk